Formulation design & development of piroxicam emulgel

International Journal of PharmTech Research

Volumn 4, Issue 3, 2012, Pages 1332-1344

  Khunt, Dignesh M ^a   Mishra, Ashish D ^a   Shah, Dinesh R ^a  

^a UKA TARSADIA UNIVERSITY   (India)

Author keywords

Carbopol; Emulgel; Piroxicam

Indexed keywords

CARBOMER; CETOSTEARYLIC ALCOHOL; EMULSIFYING AGENT; OLEIC ACID; PIROXICAM; POLYSORBATE 80; PROPYLENE GLYCOL; SORBITAN OLEATE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; INFLAMMATION; NONHUMAN; RAT; SKIN PENETRATION;

EID: 84870160545     PISSN: 09744304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sean C Sweetman; Martindale the Complete Drug Reference: the Pharmaceutical Press, 2009, 117-8.
2. Klaus Florey; Analytical Profile of Drug Substance: Elsevier, 15:511-30.
3. Marks R, Dykes P; Plasma and cutaneous drug levels after topical application of piroxicam gel: a study in healthy volunteers. Skin Pharmacol. 1994, 7: 340-4.
4. Monteiro-Rivier N, Imman, A, Riviere J; Topical penetration of piroxicam is dependent on the distribution of the local cutaneous vasculature. Pharm. Res. 1993, 10:1326-31.
5. Shin S, Cho C, Oh I; Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats. International Journal of Pharmaceutics. 2000, 193: 213-8.
6. Stéphanie d'Arpino, Archer V, Marty J, Lantieri L, Vincent C; Influence of Vehicles on the In-vitro percutaneous absorption of piroxicam to optimise the formulation of patch tests in dermatology. Drug Development Research. 2003, 58: 283-90.
7. Santoyo S, Ygartua P; Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. European Journal of Pharmaceutics and Biopharmaceutics. 2000, 50: 245-50.
8. Curdy C, Yogeshvar N, Naik A, Richard H; Piroxicam delivery into human stratum corneum: in-vivo iontophoresis versus passive diffusion. Journal of Controlled Release, 2001; 76: 73-9.
9. Murthy S, Zhao Y, Sen A, Wen Hui S. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation. Journal of Controlled Release. 2004, 99: 393-402.
10. Okuyama H, Ikeda Y, Kasai S; Influence of non- ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm. International Journal of Pharmaceutics. 1999, 186: 141-148.
11. Rieger M, Lachman L, Lieberman H, Kanig J; The Theory and Practice of Industrial Pharmacy: 3rd ed. PA Lea and Febiger: Philadelphia: 1986, 502-33.
12. Khullar R, Saini S, Seth N, Rana A; Emulgels: A surrogate approach for topically used hydrophobic drugs. International Journal of Pharmacy and Biological Sciences. 2011, 1: 117-28.
13. Dash S, Murthy P, Nath L, Chowdhury P; Kinetic modeling of drug release from controlled drug delivery systems. Acta Poloniae Pharmaceutical Drug Research. 2010, 67: 217-23.
14. Costa P, Lobo M; Modeling and comparison of dissolution profile. European Journal Pharmaceutical Sciences. 2001. 13: 123-33.
15. Desai K; Enhanced skin permeation of rofecoxib using topical microemulsion gel. Drug Development and Research. 2004, 63: 33-40.
16. Bachhav Y, Patravale V; Microemulsion based vaginal gel of fluconazole: Formulation, in vitro and in-vivo evaluation. International Journal of Pharmaceutics. 2009, 365: 175-9.
17. Boughton-Smith N, Deakin A, Follenfant R. Whittle BJ, Garland LG; Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br. J Pharmacol. 1993, 110: 896-902.
18. Puri R, Sanghavi N. Evaluation of Topical Non-Steroidal Drugs of Using Penetration Enhancers. Indian Journal of Pharmacology. 1992, 24(4): 227-8.